Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.52 USD | +0.67% | -3.20% | +71.32% |
05-08 | Design Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | Piper Sandler Upgrades Design Therapeutics to Overweight From Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.32% | 254M | |
+28.92% | 49.18B | |
+1.10% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.80% | 26.09B | |
-22.12% | 18.71B | |
+7.96% | 13.26B | |
+32.50% | 12.32B | |
-0.40% | 11.99B |
- Stock Market
- Equities
- DSGN Stock
- News Design Therapeutics, Inc.
- SVB Downgrades Design Therapeutics to Market Perform From Outperform, Cuts Price Target to $6 From $22